NPCE NeuroPace
- 8.170
- -0.390-4.56%
- 8.220
- +0.050+0.61%
NeuroPace News
NeuroPace | 10-Q: Quarterly report
NeuroPace | 8-K: NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | ARS: Annual Report to Security Holders
NeuroPace | DEFA14A: Others
NeuroPace | DEF 14A: Definitive information statements
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC
NeuroPace | 144: Notice of proposed sale of securities pursuant to Rule 144
NeuroPace | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
NeuroPace | 10-K: Annual report
NeuroPace | 8-K: Current report
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Officer Morrell Martha
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Officer Kuhn Rebecca
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Officer Becker Joel
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(15.2%),OrbiMed Capital GP VI LLC(15.2%)
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KCK Ltd.(21.3%)
NeuroPace | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(9.4%),Morgan Stanley Capital Services LLC(9.3%)
Analysis
Price Target
No Data
